Senores Pharmaceuticals IPO includes 1.28 crore fresh shares worth ₹500 crores and 0.21 crore OFS worth ₹82.11 crores, aiming to fund growth, repay debt, and boost working capital.
Open Date : December 20, 2024 Close Date : December 24, 2024 Allotment Date: December 26, 2024 Listing Date: December 30, 2024
IPO Price: INR 372-391 per share Lot Size: 38 Shares Total Issue Size: INR 582.11 crores
Senores Pharmaceuticals IPO shows mixed performance: 1. Strong revenue growth. 2. Increased equity & liabilities. 3. Higher PAT & EPS. 4. Improved RoNW. 5. Expanded total assets.
Senores Pharmaceuticals IPO Comparison: 1. Senores Pharmaceuticals shows growth among peers: Ajanta, Alembic, Caplin, Gland, and Strides. 2. Strong potential in profitability and market positioning.
Senores Pharmaceuticals IPO Objective: 1. Invest in subsidiaries. 2. Fund sterile injection manufacturing. 3. Repay borrowings. 4. Support working capital.
Senores Pharmaceuticals IPO Risks: 1. Reliance on marketing agreements. 2. Market growth risks. 3. Strict quality standards. 4. Risks: recalls, legal issues, and financial setbacks.